Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

(CNN) — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

By Deidre McPhillips, CNN

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits

By Deidre McPhillips, CNN (CNN) — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough. An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications –

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough.